Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21
1996

Loss of Heterozygosity on Chromosome 5q in Ovarian Cancer

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): M Tavassoli, H Steingrimsdottir, E Pierce, X Jiang, M Alagozl, F Farzaneh, IG Campbell

Primary Institution: King's College School of Medicine and Dentistry

Hypothesis

Does loss of heterozygosity on chromosome 5q in ovarian cancer correlate with TP53 mutations?

Conclusion

The study found a significant association between loss of heterozygosity on chromosome 5q and TP53 mutations in ovarian cancer.

Supporting Evidence

  • 47% of the tumors showed loss of heterozygosity on chromosome 5q.
  • 78% of tumors with 5q LOH also had TP53 mutations.
  • 33% of stage I tumors exhibited 5q LOH.

Takeaway

In ovarian cancer, many tumors lose genetic information on chromosome 5, and this often happens alongside changes in a gene called TP53, which helps control cell growth.

Methodology

The study analyzed 49 ovarian tumors for loss of heterozygosity using microsatellite markers and examined TP53 mutations.

Limitations

The study may not fully represent all ovarian cancer types due to the specific tumor collection.

Participant Demographics

Patients undergoing surgery for primary ovarian cancer.

Statistical Information

P-Value

<0.001

Confidence Interval

90% CI (0.462-0.756)

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication